Show simple item record

dc.contributor.authorWorld Health Organizationen
dc.coverage.spatialGeneva
dc.date.accessioned2012-06-16T14:29:57Z
dc.date.available2012-06-16T14:29:57Z
dc.date.created1998en
dc.date.issued1998en
dc.identifier.isbn9241545224
dc.identifier.urihttps://apps.who.int/iris/handle/10665/42088
dc.description68 p.en
dc.language.isoenen
dc.language.isofren
dc.publisherWorld Health Organization
dc.publisherWorld Health Organization
dc.subject.meshOsteoporosisen
dc.subject.meshLegislation, Drugen
dc.subject.meshClinical Trialen
dc.subject.meshDrug Evaluation, Preclinicalen
dc.subject.meshEvidence-Based Medicineen
dc.subject.meshGuidelineen
dc.subject.otherPharmaceuticals and Biologicalsen
dc.titleGuidelines for preclinical evaluation and clinical trials in osteoporosisen
dc.title.alternativeDirectives pour l' évaluation préclinique et les essais cliniques concernant l' ostéoporoseen
dc.subject.meshqualifierdrug therapyen
dc.subject.meshqualifiermethodsen
who.relation.languageVersion10665/42300en


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record